Why Is Türkiye More Affordable Than Other Countries? One of the most essential factors in building a healthy society and maintaining a high quality of life is the proper use of medicines. Pharmaceuticals allow individuals to manage health problems arising from genetic or environmental factors and continue to live healthier, more productive lives. Even cancer, one of the most challenging diseases of our time, can be treated with advanced oncology drugs. In developed countries, well-structured pharmaceutical policies provide citizens with longer and healthier lives. From the treatment of cancer and diabetes to cardiovascular diseases and other chronic conditions, medicines are indispensable in preserving public health. This demand also ensures the continuity and sustainability of the pharmaceutical industry. Turkey is among the fortunate countries in this regard. With privatization boosting production capacity, the volume of medicine manufacturing has expanded, while competitive conditions and structural advantages keep medicine prices relatively low. Supported by both the private sector and government policies, Turkey has established itself as a strong player in the production, distribution, and export of pharmaceuticals. The Global Generic Drug Market Generic medicines are chemically synthesized drugs with simpler structures compared to biologics and are modeled after original reference drugs. Widely known as “equivalent drugs,” generics must have the same pharmacological properties and therapeutic effects as the original drug and can only be marketed after the patent protection of the original expires. Today, generic medicines account for nearly one-quarter of the global pharmaceutical market. To be approved for sale, generics must demonstrate equivalent biological values to the originator drugs. Regulatory oversight is strict: the FDA governs generic drug approvals in the United States, the European Medicines Agency (EMA) monitors them within the EU, and in Turkey, the Ministry of Health carries out the evaluation. The expansion of generic production brings significant advantages. It not only increases the variety of medicines available but also reduces treatment costs and improves patient access to affordable drugs. For Turkey, this means an expanded supply of low-cost medicines, making healthcare more accessible while contributing to cost containment in public health expenditures. Pharmaceutical Industry in Turkey Since the early 1990s, Turkey’s pharmaceutical industry has undergone major transformation. Key government policies—such as the state’s withdrawal from direct drug supply to public hospitals and the closure of the SSK pharmaceutical factory—created opportunities for private sector growth. With this shift, Turkey has strengthened its position in the global pharmaceutical arena and increased the profitability of companies operating in health, medicine, and related industries. While original medicines continue to dominate the market, generic drugs also play a significant role in meeting healthcare needs. The country’s adherence to Good Distribution Practices (GDP), the establishment of modern pharmaceutical warehouses, and the expansion of parallel trade have further contributed to industry development. In addition, the emergence of domestic pharmaceutical brands and investments in over-the-counter (OTC) products have reinforced Turkey’s wholesale and retail pharmaceutical markets. Why Are Medicines Cheaper in Turkey? Despite global inflationary pressures in the pharmaceutical sector, Turkey maintains comparatively lower drug prices. Several factors explain this advantage:

• Exchange rate effect: The depreciation of the Turkish lira against the euro and other currencies makes drug prices in Turkey significantly cheaper than in many European countries.
• Skilled workforce: The presence of a young, educated, and innovative labor force contributes to efficient drug development and production.
• Geopolitical advantages: Turkey’s strategic location ensures smooth access to raw materials and reduces supply chain disruptions.
• Government support: Policies aimed at supporting the pharmaceutical sector, coupled with the private sector’s expansion, have widened the production network and kept costs under control.
• Reliability of production: The industry’s proven capacity to manufacture effective, high-quality drugs further strengthens its competitive edge.

Conclusion The Turkish pharmaceutical industry continues to grow as a result of privatization, supportive state policies, and private sector innovation. With a strong position in both original and generic drug markets, adherence to international standards, and competitive pricing, Turkey stands out as a country where access to affordable, high-quality medicines is secured. These factors not only benefit domestic healthcare but also enhance Turkey’s role in the global pharmaceutical industry.

CONTACT CUSTOMER SUPPORT

You can reach us 24/7 from any of the contact options below

Pharmasophia A.Ş.